A phase II, multi-center, randomized, double-blind, placebo-controlled, parallel-group study of the safety and efficacy of tacrolimus inhalation aerosol in subjects with persistent asthma
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2012
At a glance
- Drugs Tacrolimus (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 06 Jun 2012 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.